All Substitutes


Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
HERSIMA 440MG INJECTION_1
HERSIMA 440MG INJECTION_2
HERSIMA 440MG INJECTION_1
67% Off

Hersima 440mg Injection

Prescription Required

cold-chain

Salt Composition : Trastuzumab

Manufacturer : ALKEM LABORATORIES LTD

Origin of Medicine : India

MRP: ‚āĻ54662.74
Price : ‚āĻ18000
You Save : ‚āĻ36663 (67%)

1 Vial(s) Of 20ml

Prepaid Only. Non-Returnable

PAP Information :    Buy 3, Get 1 Free. Contact us for latest updates.


Patient Assistance Programs
Know About PAP

Program Overview: ALKEM LABORATORIES LTD, Patient Assistance Program (PAP) is dedicated to helping patients in need of Hersima 440mg injection. The program aims to provide eligible patients with access to the medication at a more affordable cost.

Program Benefits: Purchase three vials of Hersima 440mg injection, and you will receive one free vial. Therefore, if eligible, you will have to pay only Rs.54,000 for four vials, which is Rs.13,500 per vial.

With MrMed's MRP discount of Rs. 36,663 per vial and Alkem’s PAP program, the overall savings is over 1 lakh 65 thousand per purchase. 

Contact us for the latest updates on this exclusive offer. 

Eligibility Criteria: To qualify for the Hersima Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Trastuzumab 440mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.

Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].

Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Alkem can avail of it without having to purchase the medication from MrMed.

Patient Assistance Programs

Program Overview: ALKEM LABORATORIES LTD, Patient Assistance Program (PAP) is dedicated to helping patients in need of Hersima 440mg injection. The program aims to provide eligible patients with access to the medication at a more affordable cost.

Program Benefits: Purchase three vials of Hersima 440mg injection, and you will receive one free vial. Therefore, if eligible, you will have to pay only Rs.54,000 for four vials, which is Rs.13,500 per vial.

With MrMed's MRP discount of Rs. 36,663 per vial and Alkem’s PAP program, the overall savings is over 1 lakh 65 thousand per purchase. 

Contact us for the latest updates on this exclusive offer. 

Eligibility Criteria: To qualify for the Hersima Patient Assistance Program (PAP), you must meet specific criteria, including having a valid prescription for Trastuzumab 440mg from a medical oncologist and being an Indian patient with a valid identity card. Eligibility is determined based on the diagnosed condition and program-specific requirements.

Contact Information: If you have any questions or need assistance with the application process, our dedicated patient support team is here to help. You can reach us by phone at 89391 69999 or email us at [email protected].

Please note that MrMed is not involved in the PAP program. They offer free consultations to patients to provide information about the program. Patients eligible for the PAP program by Alkem can avail of it without having to purchase the medication from MrMed.

Introduction to Hersima 440mg Injection

Hersima 440mg Injection consists of Trastuzumab as an active constituent which is indicated for its use in HER 2 breast cancer. In HER 2 positive patients, the breast cancer cells are mostly composed of HER2 proteins that cause rapid development of cancer tumor by serving as a signal to the cancerous. This medication is also used to treat metastatic gastric cancer with increased levels of HER2 proteins.

Her 2 positive breast cancer are most aggressive in nature. The targeted therapy for her 2 positive breast cancer works by selectively targeting the proteins that are responsible for the growth, development, and spread of cancer. Use effective birth control during the treatment and for at least 7 months after the final dose.

Hersima 440mg Injection is not recommended for patients aged under 18, patients who have severe breathing problems or need oxygen treatment. It is necessary to let your physician know if you have any heart problems, breathlessness, or have ever had any other cancer treatment. Make sure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medication.


Uses of Hersima 440mg Injection

Hersima 440mg Injection is indicated for its use in the following conditions:

  • Advanced and metastatic breast cancer
  • Metastatic gastric cancer

Therapeutic Effects of Hersima 440mg Injection

The protein called HER2 (human epidermal growth factor receptor 2) is found in abundant amounts on the surface of certain cancer cells, where it stimulates cancer growth. Hersima  440mg Injection selectively binds to HER2 and stops the growth of cancer cells.


Interaction of Hersima 440mg Injection with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Hersima 440mg Injection and cause undesirable side effects.


More Information about Hersima 440mg Injection

  • Keep Hersima¬†440mg Injection¬†out of sight and reach of children.
  • Store between 2ňöC and 8ňöC.

How to consume Hersima 440mg Injection

  • Hersima¬†440mg Injection shall either be administered before or after surgery.
  • It will be given as an Intravenous infusion for 90 minutes, if well tolerated it shall be administered within 30 minutes for the next doses.

Safety Advices for Hersima 440mg Injection

Image Not Available  

Pregnancy

  

Discuss with your physician before taking this Hersima 440mg Injection if you are pregnant or think you might be pregnant. Do not take this medicine during the pregnancy unless advised by the doctor to take as it may cause to the unborn baby.

Image Not Available  

Breast Feeding

  

Avoid breastfeeding your baby while on the treatment with Hersima 440mg Injection atleast for at least seven months after the final dose.

Image Not Available  

Lungs

  

Talk to your doctor if you have any lung conditions before starting treatment with Hersima 440mg Injection. 

Image Not Available  

Liver

  

You need to tell your physician if you have any liver disorders before starting Hersima 440mg Injection as it requires dosage adjustment for severe liver impairment.

Image Not Available  

Alcohol

  

Consult your doctor to know if it is safe to consume alcohol while you are on treatment with Hersima 440mg Injection.

Image Not Available  

Driving

  

Hersima 440mg Injection can cause unusual tiredness and dizziness. Hence, it is advised to avoid driving or handling machinery during the treatment.


Side Effects of Hersima 440mg Injection

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

Serious

  • Heart Problems
  • Allergic reactions
  • Kidney problems
  • Breathing difficulties

Common

  • Fever
  • Visual disturbances
  • Nose bleeds or runny nose
  • Hair loss
  • Dizziness
  • Nail disorders
  • Weight loss
  • Loss of appetite
  • Bruising
  • Dry mouth
  • Liver¬† inflammation
  • Muscle pain
  • Asthma/ lung disorders

Word of Advice

It is suggested to inform your doctor if you have a history of allergic reactions to Hersima 440mg Injection to avoid life-threatening complications. If you have a history of lung disorder or breathing problems inform your doctor beforehand before the treatment commencement. Avoid planning for pregnancy and breastfeeding for a minimum of 7 months after the last dose. Monitor your heart parameters regularly during the treatment with Hersima 440mg Injection as it may impact the functioning of heart.


FAQs

Q 1. Is Hersima 440mg Injection used as a monotherapy in treating breast cancer?

Hersima 440mg Injection is generally given along with the chemotherapy medication such as paclitaxel or docetaxel or platinum compunds. Sometimes, it is also given with hormonal agents for those patients with elevated hormonal status.

Q 2. Does Hersima 440mg Injection cause heart problems?

Yes, Hersima 440mg Injection can damage the heart muscles. Hence to prevent the worsening of symptoms, it is advised to do heart check up every 3 months and continue till 2-5 years after the treatment completion.

Q 3. Can I breastfeed while on treatment with Hersima 440mg Injection?

No, since tends to pass into breast milk, it is unsafe to breastfeed. Hence, It is advised not to breastfeed for a minimum of 7 months after the treatment with Hersima 440mg Injection.

Q 4. Can Hersima 440mg Injection be consumed during pregnancy?

No, it is unsafe to consume Hersima 440mg Injection while you are pregnant or this medicine can cause harm to the baby by reducing the amount of amniotic fluid,the fluid surrounding the womb. It can also cause organ developmental issues such as poor lung development when consumed during pregnancy. If you are planning for pregnancy, it is advised to discuss the birth control methods as this medicine may impair your fertility.


Fact Box of Hersima 440mg Injection

Molecule name: Trastuzumab

Therapeutic class: Anti-cancer

Pharmacological class: HER2 inhibitor

Indications: 

1. Advanced and metastatic breast cancer

2. Metastatic gastric cancer


References

1. Roche, Electronic Medicines Compendium (EMC), [Revised on Jan 2022] [Accessed on 12th July 2022],  https://www.medicines.org.uk/emc/files/pil.3856.pdf

2. Genentech Inc, [Revised on Feb 2021] [Accessed on 12th July 2022], https://www.gene.com/download/pdf/herceptin_prescribing.pdf

3. Anton Wellstein, Giuseppe Giaccone, Michael B. Atkins, and Edward A. Sausville, Pathway-Targeted Therapies: Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules, Goodman & Gilman’s Pharmacological Basis of Therapeutics, 13th Edition, 2018, 1203-1236.


Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.

4000+ products

We maintain strict quality controls on all our partner retailers, so that you always get standard quality products.

Secure Payment

100% secure and trusted payment protection

Easy Return

We have a new and dynamic return window policy for medicines and healthcare items. Refer FAQs section for more details.